Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687

por Vanhove, Marc, Wagner, Jean-Marc, Noppen, Bernard, Jonckx, Bart, Vermassen, Elke, Stitt, Alan W.
Publicado 2021

Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model

por Van Bergen, Tine, Hu, Tjing-Tjing, Little, Karis, De Groef, Lies, Moons, Lieve, Stitt, Alan W., Vermassen, Elke, Feyen, Jean H. M.
Publicado 2021